Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2005
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221308 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/05/2005EP1582589A1 Protein complex, process for producing the same and use thereof
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/05/2005EP1123389B1 A method of affinity separation and ligands for use therein
10/05/2005CN1678636A Thrombus-resolving and anticoagulation double function fusion protein and use thereof
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
10/05/2005CN1676606A Method for reconstructing target protein from protein segment in plant
10/05/2005CN1676531A Recombinant immunotoxin based on pseudomonas exotoxin containing (Arg) 9 peptide segment
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins
09/29/2005US20050214741 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor
09/29/2005US20050214314 Human cytokine receptor
09/29/2005US20050214253 Interferon-beta fusion proteins and uses
09/29/2005US20050214252 Chordin-like molecules and uses thereof
09/28/2005EP1579212A2 Methods of identifying reduced internalization transmembrane receptor agonists
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578802A1 Dna/rna transduction technology and its clinical and basic applications
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
09/28/2005EP1578364A2 Compositions and methods for the treatmentof immune related diseases
09/28/2005CN1675371A Polypeptides having a- h-a-amino acid amide racemase activity and nucleic acids encoding the same
09/28/2005CN1675355A Novel lipases and uses thereof
09/28/2005CN1675241A Immunogenic conjugates
09/28/2005CN1674934A Vaccine compositions containing amyloid beta1-6 antigen arrays
09/28/2005CN1673231A Monoclonal antibody of SARS coronavirus N protein and its application
09/27/2005US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949366 Complexing; purified polypeptide
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections
09/27/2005US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates
09/27/2005CA2139670C Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
09/27/2005CA2099612C Monokine mig induced by ifn-gamma
09/22/2005WO2005087813A1 Chimeric antigens comprising an fc-fragment for eliciting an immune response
09/22/2005WO2005087808A2 Growth factor binding constructs materials and methods
09/22/2005WO2005080418A3 Multimerised hiv fusion inhibitors
09/22/2005US20050208624 Fluorescent protein
09/22/2005US20050208552 Corpuscles of Stannius protein, stanniocalcin
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208490 Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576115A2 Protein chips
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP0804565B1 Tetracycline-regulated transcriptional modulators
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/15/2005WO2005085291A1 A kind of fusion protein, gene encoding it, expression method and use thereof
09/15/2005US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
09/15/2005US20050202529 Humanised antibodies
09/15/2005US20050202498 Linkers that provide enhanced affinity and specificity to chimeric zinc finger proteins
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor
09/15/2005US20050202033 Heat shock protein-based vaccines and immunotherapies
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005CA2563397A1 Adzymes and uses thereof
09/15/2005CA2554596A1 Il-4/il-13 specific polypetides and therapeutic uses thereof
09/14/2005EP1573294A2 Real time detection of intermolecular interaction
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon
09/14/2005EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572908A2 Chimeric molecules for cleavage in a treated host
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 295